 |
|
Natural Compound Stops Diabetic Retinopathy
July 06, 2009Compound restores balance in eye with one treatment; affects macular degeneration and cancer too
Oklahoma City, OK -- Researchers at the University of Oklahoma Health Sciences Center have found a way to use a natural compound to stop one of the leading causes of blindness in the United States. The research appears online this month in the journal Diabetes, a publication of the American Diabetes Association.
The discovery of the compound's function in inflammation and blood vessel formation related to eye disease means scientists can now develop new therapies -including eye drops - to stop diabetic retinopathy, a disease which affects as many as five million Americans with Type 1 and Type 2 diabetes.
"There is no good treatment for retinopathy, which is why we are so excited about this work. This opens an entirely new area for pharmaceutical companies to target," said Jay Ma, the principal investigator on the project and a research partner at the OU Health Sciences Center, Dean A. McGee Eye Institute and the Harold Hamm Oklahoma Diabetes Center.
Diabetic retinopathy is the most common diabetic eye disease and a leading cause of blindness in American adults. It is caused by changes in blood vessels of the retina, the light-sensitive tissue at the back of the eye. In some people with diabetic retinopathy, blood vessels may swell and leak fluid. In other people, abnormal new blood vessels grow on the surface of the retina. Over time, diabetic retinopathy can get worse and cause some vision loss or blindness.
Oklahoma researchers found that this inflammation and leakage is caused by an imbalance of two systems in the eye. To restore balance, they delivered the new compound to cells using nanoparticle technology. The treatment in research models stopped the leakage, blocked inflammation and kept unwanted blood vessels from growing. Researchers are now testing the compound's uses for cancer and age-related macular degeneration.
Dr. Ma's research is funded by the American Diabetes Association and the National Institutes of Health.
The University of Oklahoma Health Sciences Center
"There is no good treatment for retinopathy, which is why we are so excited about this work. This opens an entirely new area for pharmaceutical companies to target," said Jay Ma, the principal investigator on the project and a research partner at the OU Health Sciences Center, Dean A. McGee Eye Institute and the Harold Hamm Oklahoma Diabetes Center.
Diabetic retinopathy is the most common diabetic eye disease and a leading cause of blindness in American adults. It is caused by changes in blood vessels of the retina, the light-sensitive tissue at the back of the eye. In some people with diabetic retinopathy, blood vessels may swell and leak fluid. In other people, abnormal new blood vessels grow on the surface of the retina. Over time, diabetic retinopathy can get worse and cause some vision loss or blindness.
Oklahoma researchers found that this inflammation and leakage is caused by an imbalance of two systems in the eye. To restore balance, they delivered the new compound to cells using nanoparticle technology. The treatment in research models stopped the leakage, blocked inflammation and kept unwanted blood vessels from growing. Researchers are now testing the compound's uses for cancer and age-related macular degeneration.
Dr. Ma's research is funded by the American Diabetes Association and the National Institutes of Health.
The University of Oklahoma Health Sciences Center
Diabetic Retinopathy Current Events and Diabetic Retinopathy News RSSCataract surgery helps AMD patients; steroid improves DME; online eye health forum
This month's Ophthalmology, the journal of the American Academy of Ophthalmology (Academy) reports on a national study that finds cataract surgery is likely to benefit patients with age-related macular degeneration (AMD) at all stages of the disease, on a clinical trial showing that the steroid triamcinolone may be effective in advanced diabetic macular edema (DME) patients when standard treatment fails, and on the public's use of two Academy-sponsored online eye health forums.
Clues to visual variant Alzheimer's; myopia and diabetic retinopathy risk
Two studies are of particular note in today's Scientific Program of the 2009 Joint Meeting of the American Academy of Ophthalmology (AAO) and the Pan-American Association of Ophthalmology (PAAO): a report by Swiss neuro-ophthalmic researchers about vision exam clues that should make ophthalmologists suspect an atypical variant of Alzheimer's disease; and new evidence from a Singapore National Eye Center study that diabetics who are nearsighted may be less susceptible to diabetic retinopathy.
Treating ROP in tiny preemies; better glaucoma follow-up in urban clinic
Highlights of today's Scientific Program of the 2009 American Academy of Ophthalmology (AAO) - Pan-American Association of Ophthalmology (PAAO) Joint Meeting include: John T. Flynn, MD, Columbia University School of Medicine, discussing the ever-tougher challenges Eye M.D.s face in caring for the vision of the tiniest premature babies; and a report by Bradford W. Lee, MD, Stanford University School of Medicine, on barriers to glaucoma follow-up as perceived by patients in an urban, culturally diverse clinic.
First in New York: Bionic technology aims to give sight to woman blinded beginning at age 13
A 50-year-old New York woman who was diagnosed with a progressive blinding disease at age 13 was implanted with an experimental electronic eye implant that has partially restored her vision.
Elevated arginase levels contribute to vascular eye disease such as diabetic retinopathy
Elevated levels of the enzyme arginase contribute to vascular eye damage and Medical College of Georgia researchers say therapies to normalize its levels could halt progression of potentially blinding diseases such as diabetic retinopathy.
Erectile dysfunction treatments do not appear to damage vision over 6 months
Two medications used to treat erectile dysfunction in men (tadalafil and sildenafil) do not appear to have visual side effects when taken daily for six months, despite concerns about eye-related complications.
Growth factor TGF-B helps maintain health of retinal blood vessels
Scientists at Schepens Eye Research Institute have found that the growth factor known as TGF-β is essential to the health of blood vessels in the retina and that blocking it can cause retinal dysfunction.
South Asians with diabetes more likely to lose their eyesight earlier than White Europeans
South Asians with type 2 diabetes are significantly more at risk of losing their eyesight and losing it at an earlier age, compared to White Europeans with the same condition.
Shining light on diabetes-related blindness
A group of scientists in California is trying to develop a cheaper, less invasive way to spot the early stages of retinal damage from diabetic retinopathy, the leading cause of blindness in American adults, before it leads to blindness.
ORNL, UT project could save vision of millions
In the blink of an eye, people at risk of becoming blind can now be screened for eye diseases such as diabetic retinopathy and age-related macular degeneration.
More Diabetic Retinopathy Current Events and Diabetic Retinopathy News Articles
 |
Diabetic Retinopathy (Contemporary Diabetes) by Elia Duh (Editor) Diabetic retinopathy is the most common microvascular complication of diabetes. It remains a major cause of new-onset visual loss in the United States and other industrialized nations. In Diabetic Retinopathy, Elia Duh and a panel of internationally recognized experts comprehensively assess the current state of knowledge regarding the clinical management of DR as well as its underlying mechanisms. The authors outline the current understanding of diabetic retinopathy from the perspective of clinical practice, while reviewing the multi-factorial pathogenesis and pathophysiology of DR from the standpoint of biomedical research. Also included is a discussion of emerging concepts relating to the management and treatment of DR. Informative and highly-practical, Diabetic Retinopathy provides... |
 |
Diabetic Retinopathy for the Comprehensive Ophthalmologist by Jonathan D. Walker (Author), Lauren Fath (Editor), M. Walt Keys (Editor) This book is designed to transfer useful skills for the clinical management of diabetic patients. The target audience is residents, beginning retina fellows and comprehensive ophthalmologists interested in fine-tuning their approach to diabetic retinopathy. Further information and sample downloads of the book are available at drcobook.com |
 |
Diabetic Retinopathy: From Screening to Treatment (Oxford Diabetes Library) by Paul Dodson (Editor) Current guidelines state that 100% of patients with diabetes should be screened for retinal problems. This pocketbook is a concise companion for professionals involved in sreening and treating diabetic retinopathy (DR). It explains why screening is required, the different screening models available with their advantages and disadvantages, and the different DR grades. The book also describes specific problems such as ophthalmic lesions, which may present themselves as DR and covers the treatment of DR from both a medical and an ocular perspective. This book is presented in full color and contains over 100 images. Each chapter is written with a specfic role in a DR screening scheme. |
|
Diabetic Retinopathy: Current Management of the Patient with Cerebral Ischemia: Update Total Joint Replacement--VHS Videotape, The Network for Continuing Medical Education. Includes guide pamphlet. | |
 |
Understanding Diabetic Retinopathy |
 |
Large Print English Keyboard Overlay / Stickers - Black Large Font Characters on a Off-White Ivory White Background by DataCal Large Print English Letters are printed in boldface type and are approximately the same size as the keys. Crack-and-peel-proof overlays conform to the curves of the keys surface, creating a strong yet removable bond. Durable, Lexan polycarbonate construction with non-glare surface. Legends will not wear off, even after repeated use. |
|
Management of Diabetic Retinopathy for the Primary Care Physician [VHS] Starring: DRSR Group, ETDRSR Group | |
 |
Large Print Italian USB Computer Keyboard for Visually Impaired - Yellow Keys with Black Letters by Keys-U-See Keys-U-See Italian Large Print Yellow USB Computer Keyboard. The Keys-U-See® USB big print computer keyboard is designed for those who have a hard time seeing the existing commands on the standard keyboard. Particularly for those with conditions that cause visual impairment or low vision such as macular degeneration, glaucoma, diabetic retinopathy, cataracts, or age. This user-friendly large print keyboard also has 12 "hot keys" providing easy access to common functions. It is a full size enhanced 105 key keyboard with Swedish keyboard layout printed in big bold easy to read typeface on the keycaps and features high contrast yellow keys with black printing. The keyboard is manufactured with high quality membrane switches designed to withstand over 10 million keystrokes. Power Rating: 5... |
 |
KARELA by RAMSEY Karela, also known as Bitter Gourd, has been traditionally used to regulate blood sugar levels within the normal limits. It contains Gurmarin, a polypeptide that has been shown in experimental studies to achieve its regulating effect by suppressing the neural response to sweet taste stimuli. Bitter Melon is also a natural source of Vitamin C. Are there any available references and research on Karela? Sarkar, S., et al. "Demonstration of the hypoglycemic action of Momordica charantia in a validated animal model of diabetes." Pharmacol. Res. 1996; 33(1): 1-4. Akhtar, M. S. "Trial of Momordica charantia Linn (Karela) powder in patients with maturity-onset diabetes." J. Pak. Med. Assoc. 1982; 32(4):106-7. |
 |
Diabetic Retinopathy Atlas by Vishali Gupta (Author), Amod Gupta (Author), M.R. Dogra (Author), Ramandeep Singh (Author) A comprehensive, uniquely focused management guide to diabetic retinopathy Because few texts focus exclusively on diabetic retinopathy, Diabetic Retinopathy Atlas is both timely and time-saving, a one-of-a-kind source of state-of-the-art diagnostic and treatment techniques for dealing with this affliction. Offered throughout are hands-on guidelines for performing the eye screenings, laser photocoagulation, and surgery that prevent or manage the visual impairment caused by diabetic retinopathy. Incorporates current information on all aspects of diabetic retinopathy into actual patient management strategies Targets essential information within each chapter with succinct, time-saving key points sections 600 full-color photos and... |
| © 2009 BrightSurf.com |